Mirae Asset Global ETFs Holdings
RCUS icon

Mirae Asset Global ETFs Holdings’s Arcus Biosciences RCUS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
47,511
+5,556
+13% +$120K ﹤0.01% 1517
2025
Q4 		$997K Buy
41,955
+6,590
+19% +$134K ﹤0.01% 1519
2025
Q3 		$480K Sell
35,365
-7,477
-17% -$77.7K ﹤0.01% 1881
2025
Q2 		$348K Buy
42,842
+5,270
+14% +$45K ﹤0.01% 1998
2025
Q1 		$297K Buy
37,572
+3,565
+10% +$41.3K ﹤0.01% 2116
2024
Q4 		$506K Buy
34,007
+833
+3% +$13.6K ﹤0.01% 1912
2024
Q3 		$508K Buy
33,174
+1,909
+6% +$30.1K ﹤0.01% 1901
2024
Q2 		$476K Buy
+31,265
New +$505K ﹤0.01% 1848

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RCUS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Arcus Biosciences (RCUS) stake by 13% in Q1 2026, buying an estimated $120K and bringing the position to 47,511 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Mirae Asset Global ETFs Holdings first reported a position in RCUS in Q2 2024 and has held it in 8 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 47,511 shares of Arcus Biosciences worth $1.02M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 5,556 Arcus Biosciences shares in Q1 2026, an estimated $120K.
  • Arcus Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1517 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Arcus Biosciences in Q2 2024 and has held it in 8 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.